Core Insights - The Hong Kong stock market opened positively on November 24, with the Hang Seng Index rising by 0.92%, the Hang Seng Tech Index by 1.13%, and the Hang Seng China Enterprises Index by 0.81% [1] - Notable sectors included technology stocks, gold stocks, innovative drug concepts, lithium battery stocks, and automotive stocks, indicating active market participation and strong capital interest [1] - The inclusion of Innovent Biologics, a significant biotech company, into the Hang Seng Index reflects the growing recognition and importance of quality Chinese innovative drug companies in the mainstream capital market [1] Market Performance - The Hang Seng Index and related ETFs, such as the Hang Seng ETF (159920) and Hang Seng China Enterprises ETF (159850), experienced a strong opening and continued to rise throughout the trading session [1] - The market showed active trading with significant attention from investors, highlighting a positive sentiment towards the Hong Kong stock market [1] Company Developments - Innovent Biologics has become the fourth innovative drug company to be included in the Hang Seng Index, joining other companies that have transitioned from traditional pharmaceuticals to innovative drug enterprises [1] - This inclusion signifies a benchmark status for Innovent Biologics and underscores the increasing focus on high-quality Chinese biotech firms in the international market [1]
信达生物获纳恒指，港股市场对优质中国创新药企或愈加重视